Tigran Yuzbashev

Tigran’s primary research interest is in discovery and engineering of new metabolic pathways in a variety of living forms. During more than two decades he developed industrial technologies, including production of organic acids, amino acids, vitamins, lipids, terpenoids, and enzymes. Tigran graduated from Moscow State University where after getting a PhD he taught lectures on Metabolic Engineering. In 2019 he moved to the UK and completed a 3 year post-doc at Imperial College.

At the department of Plant Sciences for the Bioeconomy he is working on two BBSRC projects:
• Discovering new biosynthetic pathways of willow leading to formation of Miyabeacin, the new highly-potent drug active against a number of cancer cell lines. These include neuroblastoma, which is the most frequent extracranial solid childhood tumour.
• He is leading a Synthetic Biology project to revolutionise the way we are building genes and genomes. InViDA technology (for in vivo DNA assembly) utilizes CRISPRs to build DNA quicker, cheaper and to make the process better for the environment, as it greatly reduces consumable and hazard wastes.